Cargando…

Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice

Accurate diagnosis and appropriate treatment of tardive dyskinesia (TD) are imperative, as its symptoms can be highly disruptive to both patients and their caregivers. Misdiagnosis can lead to incorrect interventions with suboptimal or even deleterious results. To aid in the identification and diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauser, Robert A., Meyer, Jonathan M., Factor, Stewart A., Comella, Cynthia L., Tanner, Caroline M., Xavier, Rose Mary, Caroff, Stanley N., Lundt, Leslie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249122/ https://www.ncbi.nlm.nih.gov/pubmed/33213556 http://dx.doi.org/10.1017/S109285292000200X

Ejemplares similares

Recent Advances in the Pharmacology of Tardive Dyskinesia
por: Caroff, Stanley N.
Publicado: (2020)

Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia
por: Caroff, Stanley N., et al.
Publicado: (2018)

Overcoming barriers to effective management of tardive dyskinesia
por: Caroff, Stanley N
Publicado: (2019)

Tardive Dyskinesia in Older Persons Taking Antipsychotics
por: Citrome, Leslie, et al.
Publicado: (2021)

Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia
por: Caroff, Stanley N., et al.
Publicado: (2020)

An Experimental Study to Assess the Professional and Social Consequences of Tardive Dyskinesia
por: Ayyagari, Rajeev, et al.
Publicado: (2022)

Effect of Varenicline on Tardive Dyskinesia: A Pilot Study
por: Caroff, Stanley N., et al.
Publicado: (2021)

Patient perspective of tardive dyskinesia: results from a social media listening study
por: Farrar, Mallory, et al.
Publicado: (2021)

Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia—Key Differences in Pathophysiology and Clinical Management
por: Ward, Kristen M., et al.
Publicado: (2018)

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia
por: Fernandez, Hubert H, et al.
Publicado: (2019)

RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings
por: Caroff, Stanley N., et al.
Publicado: (2020)

Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study
por: Cutler, Andrew J., et al.
Publicado: (2021)

A Survey of the Tardive Dyskinesia Induced by Antipsychotic Drugs in Patients with Schizophrenia
por: Hemmati, Sahel, et al.
Publicado: (2010)

Delayed Presentation of Antipsychotic Withdrawal Tardive Dyskinesia: A Case Report
por: Solanki, Siddhant, et al.
Publicado: (2023)

METOCLOPRAMIDE IN TARDIVE DYSKINESIA
por: Hemanani, T.J., et al.
Publicado: (1983)

Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study
por: Tanner, Caroline M., et al.
Publicado: (2023)

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study
por: Fernandez, Hubert H., et al.
Publicado: (2017)

Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?
por: Hu, Jianbo, et al.
Publicado: (2017)

Tardive dyskinesia occurring in a young woman after withdrawal of an atypical antipsychotic drug
por: Alblowi, Mohammed A., et al.
Publicado: (2015)

Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia
por: Sharma, Vibhash D., et al.
Publicado: (2020)

Dysphagia due to tardive dyskinesia
por: Bhat, Pookala S., et al.
Publicado: (2010)

RISK FACTORS FOR TARDIVE DYSKINESIA
por: Datta, Sunil, et al.
Publicado: (1994)

PESISTENT PARKINSONISM AND TARDIVE DYSKINESIA
por: Shaji, K.S., et al.
Publicado: (1995)

Amoxapine-induced tardive dyskinesia
por: Singh, Gurvinder Pal
Publicado: (2009)

Tardive Dyskinesia: Treatment with Aripiprazole
por: Kang, Na-Ri, et al.
Publicado: (2011)

Reversibility of Tardive Dyskinesia Syndrome
por: Vinuela, Angel, et al.
Publicado: (2014)

Amisulpride Reexposure and Tardive Dyskinesia
por: Sidana, Ajeet
Publicado: (2018)

Tardive Dyskinesia Associated with Bupropion
por: Tuman, Taha Can, et al.
Publicado: (2017)

Clozapine-induced Tardive Dyskinesia
por: Das, Soumitra, et al.
Publicado: (2017)

Improvement of Tardive Dyskinesias with Olanzapine
por: Echater, S., et al.
Publicado: (2023)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
por: Adam, Usman U, et al.
Publicado: (2014)

Tardive dyskinesia with clozapine dose reduction or withdrawal dyskinesia?
por: Praharaj, Samir Kumar
Publicado: (2011)

Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States
por: Loughlin, Anita M., et al.
Publicado: (2019)

NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study
por: O'Brien, Christopher F., et al.
Publicado: (2015)

TETRABNAZINE FOR ISOLATED SHOULDER TARDIVE DYSKINESIA
por: Basu, Soumya, et al.
Publicado: (2001)

LOW DOSE LEVODOPA IN TARDIVE DYSKINESIA
por: Sethi, Sujata, et al.
Publicado: (1990)

Tardive dyskinesia with low dose amisulpride
por: Tharoor, Hema, et al.
Publicado: (2013)

Treatment of neurolept-induced tardive dyskinesia
por: Jankelowitz, Stacey K
Publicado: (2013)

Facial mask masking tardive dyskinesia
por: Ganhao, I.
Publicado: (2021)

Pathophysiology, prognosis and treatment of tardive dyskinesia
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_771hbrbta23f97tg3qck92bmt4